ImmunityBio (IBRX) Free Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.27% |
| Dec 31, 2025 | -1.11% |
| Sep 30, 2025 | 13.07% |
| Jun 30, 2025 | 5.59% |
| Mar 31, 2025 | -6.89% |
| Dec 31, 2024 | 20.86% |
| Sep 30, 2024 | -0.48% |
| Jun 30, 2024 | 6.63% |
| Mar 31, 2024 | 12.16% |
| Dec 31, 2023 | -25.69% |
| Sep 30, 2023 | -34.80% |
| Jun 30, 2023 | 29.62% |
| Mar 31, 2023 | -13.62% |
| Dec 31, 2022 | -14.24% |
| Sep 30, 2022 | 23.18% |
| Jun 30, 2022 | -36.39% |
| Mar 31, 2022 | -26.37% |
| Dec 31, 2021 | 31.30% |
| Sep 30, 2021 | -18.80% |
| Jun 30, 2021 | -13.81% |
| Mar 31, 2021 | -13.76% |
| Dec 31, 2020 | -53.83% |
| Sep 30, 2020 | 22.97% |
| Jun 30, 2020 | -52.58% |
| Mar 31, 2020 | 70.42% |
| Dec 31, 2019 | -467.07% |
| Sep 30, 2019 | -16.53% |
| Jun 30, 2019 | -6.59% |
| Mar 31, 2019 | -97.76% |
| Dec 31, 2018 | 64.02% |
| Sep 30, 2018 | -13.20% |
| Jun 30, 2018 | 8.11% |
| Mar 31, 2018 | -8,535.12% |
| Dec 31, 2017 | 101.16% |
| Sep 30, 2017 | 9.76% |
| Jun 30, 2017 | -58.63% |
| Mar 31, 2017 | -20.27% |
| Dec 31, 2016 | 12.00% |
| Sep 30, 2016 | -47.08% |
| Jun 30, 2016 | 5.70% |
| Mar 31, 2016 | 16.61% |
| Dec 31, 2015 | -123.12% |
| Sep 30, 2015 | -83.64% |
| Jun 30, 2015 | 60.81% |
| Mar 31, 2015 | -183.80% |
| Dec 31, 2014 | -179.55% |
| Sep 30, 2014 | 54.51% |
| Jun 30, 2014 | -5,302.63% |